News

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Verywell Health on MSN3h
Navigating an MCRPC Diagnosis
Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...
Vitamin B12 is crucial for nerve function, red blood cell formation, and DNA production, yet many, especially vegetarians, ...
The connection was so striking that in 2007 the Food and Drug Administration required a black box warning label ... liver cancer into the animals’ tail vein or by implanting liver cancer cells ...
Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...
Nika Beamon set out on a journey, and 26 doctors, 37 procedures and more than 17 years later, a rheumatologist finally ...